본문 바로가기

N,N '-Bis(5-aminosalicyl)-L-Cystine Is a Potential Colon-Specific 5-Aminosalicylic Acid Prodrug with Dual Therapeutic Effects in Experimental Colitis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
JOURNAL OF PHARMACEUTICAL SCIENCES98(1) · pp.159 · 2009
피인용
Web of Science 9
JCR IF
JCR 2008 2.996
ISSN
0022-3549

저자

  1. Kim, Heejung제1저자부산대학교, 약학대학, Lab Biomed Chem, Coll Pharm, KO
  2. 허정순부산대학교, KO
  3. 전현주부산대학교, 약학대학, 약학부, 제약학전공, KO
  4. 최대규부산대학교, 약학대학, 약학부, 제약학전공, KO
  5. Han, Jungoh부산대학교, 약학대학, Lab Biomed Chem, Coll Pharm, KO
  6. 김영미부산대학교, 약학대학, 약학부, 제약학전공, KO
  7. 정연진부산대학교, 약학대학, 약학부, 제약학전공, KO

초록

To evaluate N,N'-bis(5-aminosalicyl)-L-cystine (5-ASA-Cys) as a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis, the pharmacokinetics and therapeutic activity were investigated after oral administration of 5-ASA-Cys and amelioration of experimental colitis was compared after rectal administration of 5-aminosalicylic acid (5-ASA) and/or cysteine. In addition, the gluthathione (GSH) level in the inflamed colonic tissue was examined after administration of cysteine or 5-ASA-Cys. Oral administration of 5-ASA-Cys delivered much greater amount of 5-ASA to the large intestine and excreted lower amount of 5-ASA via urine than that of free 5-ASA. Oral administration of 5-ASA-Cys ameliorated experimental colitis of rats induced by TNBS, which was more effective than that of sulfasalazine. Although cysteine administered rectally was not significantly effective, intracolonic treatment with both 5-ASA and cysteine showed a synergic effect in alleviating the rat colitis. Furthermore, not only 5-ASA-Cys administered orally but also cysteine administered rectally increased the glutathione level in the inflamed colonic tissue. Taken together, these results suggest that 5-ASA-Cys is a potential colon specific 5-ASA prodrug with dual therapeutic effects on experimental colitis and cysteine modulation of the glutathione level may be relevant to the dual effects of the prodrug. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:159-168, 2009

키워드

colon-specific prodrug5-aminosalicylic acidcystineglutathione and colitisINFLAMMATORY-BOWEL-DISEASEINTESTINAL INFLAMMATIONEPITHELIAL-CELLSN-ACETYLCYSTEINEDRUG-DELIVERYMODELMETABOLISMANTIOXIDANTSGLUTATHIONETRANSPORT

식별자

WoS UID
000262228600014